| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 79.9159 | 72 |
| GSM780708 | Untreated after 4 days (C2_1) | 97.8641 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 93.8514 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 79.8547 | 72 |
| GSM780720 | Untreated after 4 days (C2_2) | 89.9947 | 74 |
| GSM780721 | Untreated after 4 days (C3_2) | 81.1186 | 72 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 96.7352 | 75 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 80.2987 | 72 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 89.4528 | 74 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 94.0897 | 74 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 105.324 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 116.117 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 78.6425 | 71 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 95.1835 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 82.3261 | 72 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 92.3432 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 128.027 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 97.6559 | 75 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 95.7733 | 75 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 92.89 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 90.8219 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 91.026 | 74 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 94.2357 | 74 |